Strain Differences Separate Helpful and Harmful Elements of the Human Microbiome
|
By LabMedica International staff writers Posted on 12 Mar 2013 |
A recent microbiome study demonstrated the importance of evaluating bacteria at the strain rather than the genus or species level in order to understand their contribution to human health or disease.
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Investigators at the University of California, Los Angeles (USA) and collaborators at Washington University (St. Louis, MO, USA) and the Los Angeles Biomedical Research Institute (CA, USA) selected the skin disorder acne as a model to explore the relationship between the causative organism Propionibacterium acnes and the human immune system, which generates the inflammatory response that causes the characteristic pimples, redness, and blotchy skin.
The investigators compared the skin microbiome at the strain level and genome level of P. acnes between 49 acne patients and 52 healthy individuals by sampling the sebaceous units on their noses. More than 1,000 strains of the bacteria were cultured from the isolates, and the genomes of 66 of the P. acnes strains were sequenced.
Metagenomic analysis published in the February 28, 2013, online edition of the Journal of Investigative Dermatology demonstrated that although the relative abundances of P. acnes were similar, the strain population structures were significantly different in the two cohorts. Certain strains were highly associated with acne, and other strains were enriched in healthy skin.
By sequencing 66 previously unreported P. acnes strains and comparing 71 P. acnes genomes, the investigators identified potential genetic determinants of various P. acnes strains in association with acne or health. The analysis suggested that acquired DNA sequences and bacterial immune elements may have roles in determining virulence properties of P. acnes strains, and some could be future targets for therapeutic interventions. Furthermore, the results underscored the importance of strain-level analysis of the human microbiome to define the role of the microbial flora in health and disease.
"We learned that not all acne bacteria trigger pimples—one strain may actually help keep skin healthy," said senior author Dr. Huiying Li, assistant professor of molecular and medical pharmacology at the University of California, Los Angeles. "We hope to apply our findings to develop new strategies that stop blemishes before they start, and enable dermatologists to customize treatment to each patient's unique cocktail of skin bacteria."
"We were extremely excited to uncover a third strain of P. acnes that is common in healthy skin yet rarely found when acne is present," said Dr. Li. "We suspect that this strain contains a natural defense mechanism that enables it to recognize attackers and destroy them before they infect the bacterial cell. This P. acnes strain may protect the skin, much like yogurt's live bacteria help defend the gut from harmful bugs. Our next step will be to investigate whether a probiotic cream can block bad bacteria from invading the skin and prevent pimples before they start."
Related Links:
University of California, Los Angeles
Washington University
Los Angeles Biomedical Research Institute
Latest BioResearch News
- Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
- Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
- New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
- New Immune Target Could Support More Precise High Blood Pressure Treatment
- New Gene-Disease Link May Help Diagnose Rare Neurodevelopmental Disorders
- Researchers Identify Shared Molecular Networks Behind Fatigue-Related Illnesses
- Blood Metabolite Signature Predicts ALS Progression and Points to Treatment Strategy
- Whole-Blood Extracellular Vesicle Analysis Captures Molecular Signals Missed by Plasma Testing
- Age-Related Genomic Differences Could Refine Treatment Decisions in Lung Cancer
- Computational Tool Identifies Central Asthma Genes for Target Discovery
- Molecular Pathway Reveals Driver of Triple-Negative Breast Cancer Spread
- D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
- New Genetic Cause Identified for Neurodevelopmental Disorder
- New Genetic Discovery Could Support Precision Diabetes Care
- Inherited Genetic Differences Help Explain Variable CAR T-Cell Therapy Outcomes
- AI-Powered Genome Mapping Reveals New Layer of Alzheimer’s Disease Biology
Channels
Clinical Chemistry
view channel
Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders
Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more
Global Survey Underscores Need to Standardize Bone Biomarker Testing
Bone and mineral metabolism biomarkers can complement dual-energy X-ray absorptiometry (DXA) by providing information on disease activity and treatment response. For more than 20 years, standardization... Read more
Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis
Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more
Rapid D-Dimer Assay Supports Exclusion and Monitoring of Serious Clotting Conditions
Blood clots can rapidly become life‑threatening and affect approximately 10 million people worldwide each year. During time‑sensitive evaluations, clinicians use D‑dimer testing to help rule out deep vein... Read moreMolecular Diagnostics
view channel
Urine-Based RNA Improves Bladder Cancer Detection and Monitoring
Bladder cancer affects about 85,000 people in the United States each year and is prone to recurrence. Diagnosis and surveillance commonly rely on cystoscopy, an endoscopic examination that can miss up... Read more
Blood RNA Panel Predicts Lung Cancer Risk Years Before Diagnosis
Lung cancer may begin developing during a preclinical period when the disease remains clinically undetected, creating a challenge for identifying individuals at elevated risk years before diagnosis.... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
Blood Test Differentiates Bacterial and Viral Infections in Febrile Infants
Fever in infants younger than 3 months is treated as a medical emergency because infections can become life-threatening while the immune system is still developing. Emergency department teams must quickly... Read more
New Autoantibody Test Targets Pre-Symptomatic Type 1 Diabetes Screening
Type 1 diabetes is often first recognized only after substantial beta-cell destruction, sometimes presenting as diabetic ketoacidosis. Population-scale screening could identify children at elevated risk... Read moreMicrobiology
view channel
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more
One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more
FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures
Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more
New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment
Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read morePathology
view channel
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read more
New AI Model Maps Where Glioblastoma Could Return After Surgery
Glioblastoma is the most common malignant brain tumor in adults and the most lethal, with median survival of about 17 months after diagnosis. Even after surgeons remove all visible tumor and patients receive... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection
Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Mayo Clinic Laboratories and Pathology Asia Expand Genomic Testing Across Asia-Pacific
Mayo Clinic Laboratories and Pathology Asia Holdings (PAH), together with subsidiary LifeStrands Genomics, announced a strategic investment and collaboration focused on expanding access to advanced diagnostics... Read more





.jpg)

